Uridine Triacetate as Antidote for Patients at Excess Risk of 5-FU Toxicity Due to Overdosage or Impaired Elimination

NCT01432301 · clinicaltrials.gov ↗

APPROVED_FOR_MARKETING

Status

INDUSTRY

Sponsor class

Conditions

Toxicity Due to Chemotherapy

Interventions

DRUG: uridine triacetate

Sponsor

Wellstat Therapeutics